Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03755336 · ClinicalTrials.gov registry record · NA

Variability and Specificity in Reactive Stabilization Movements to Diverse Slip Perturbations

A NA study, sponsored by University of Nebraska.

Completed
Registry status
NA
Development phase
44
Enrollment target

NCT03755336 is a NA study that has completed, run by University of Nebraska. The registered enrollment target is 44 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03755336, a NA study, has completed, sponsored by University of Nebraska.

COMPLETED
Registry status
NA
Development phase
44 participants
Enrollment target

Study Summary

Recent research on slips has shown that use of perturbation training to improve specific motor skills to resist slips can vastly reduce falls. However, these interventions have only addressed slips occurring at heel-strike, and not the diverse range of slipping disturbances presented by a complex environment. This project will focus on slips that occur across the gait cycle, and the reactive stabilization movements that follow. Participants from two age groups will be enrolled: younger (19 - 35 years of age) and older (65-79 years of age). Each participant will participate in 3 visits within the span of 1 week. On the initial visit, participants will perform informed consent, have demographic and body measurement information collected and complete medical and physical activity questionnaires. Upper and lower body strength will be measured using a hand-held dynamometer during the first and last visits. On each of the three visits, subjects will perform a gait variability assessment followed by a diverse slip perturbation assessment. Participants will complete four slips in each of early, middle, and late stance on each visit. Measures of falls, slip severity, and reactive stabilization movements will be calculated.

Interventions

  • OTHER Administered Slip Perturbations

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2019-12-01
Est. Completion 2024-01-01
Phase NA

Sponsor

University of Nebraska

407 total trials

What the Registry Record Tells You About NCT03755336

The ClinicalTrials.gov registry entry for NCT03755336 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Administered Slip Perturbations is the first listed.

NCT03755336 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03755336 about?

NCT03755336 is a clinical study titled "Variability and Specificity in Reactive Stabilization Movements to Diverse Slip Perturbations". Recent research on slips has shown that use of perturbation training to improve specific motor skills to resist slips can vastly reduce falls. However, these interventions have only addressed slips occurring at heel-strike, and not the diverse range of slipping disturbances presented by a complex en...

What is the current status of trial NCT03755336?

This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2019-12-01. Estimated completion is 2024-01-01.

What interventions are being tested in trial NCT03755336?

The interventions under investigation include: Administered Slip Perturbations (OTHER).

Who is sponsoring clinical trial NCT03755336?

This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.